Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 5
1983 1
1984 4
1985 2
1986 1
1987 5
1988 2
1989 4
1991 2
1992 3
1993 1
1994 2
1999 1
2004 2
2005 1
2006 1
2007 4
2008 3
2009 1
2011 6
2012 3
2013 1
2014 2
2015 1
2016 6
2017 2
2018 3
2019 1
2020 8
2021 9
2022 6
2023 7
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Bupropion Hydrochloride.
Khan SR, Berendt RT, Ellison CD, Ciavarella AB, Asafu-Adjaye E, Khan MA, Faustino PJ. Khan SR, et al. Among authors: ciavarella ab. Profiles Drug Subst Excip Relat Methodol. 2016;41:1-30. doi: 10.1016/bs.podrm.2015.12.001. Epub 2016 Feb 17. Profiles Drug Subst Excip Relat Methodol. 2016. PMID: 26940167 Review.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A.
Seidizadeh O, Mollica L, Zambarbieri S, Baronciani L, Cairo A, Colpani P, Cozzi G, Pagliari MT, Ciavarella A, Siboni SM, Peyvandi F. Seidizadeh O, et al. Among authors: ciavarella a. Blood Adv. 2024 Apr 9;8(7):1725-1736. doi: 10.1182/bloodadvances.2024012626. Blood Adv. 2024. PMID: 38315875 Free PMC article.
101 results